Fierce Pharma

JPM26: Astellas CEO resists ‘rescue BD’ as $6B Xtandi patent cliff nears

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

aXichem AB: aXichem Announces Publication of CrossFit Study in Leading Sports Journal - Validates aXivite as a High-Intensity Performance Supplement

MALMÖ, Sweden, Jan. 15, 2026 /PRNewswire/ -- aXichem AB (publ), (aXichem), the developer of innovative feed additives and food supplement biotechnology, is pleased to announce the formal publication ...

ImmunityBio Reports Continued Execution and Sales Momentum With $113 Million of Preliminary Net Product Revenue—a 700% increase year-over-year

ImmunityBio, Inc. (NASDAQ: IBRX), a vertically-integrated commercial stage biotechnology company, announced today preliminary ...
Health Club Management

Claudia Schiffer invests in Healf and collaborates on wellbeing campaign

One of the UK's fastest-growing wellness companies, Healf, is collaborating with household names from the worlds of fashion, ...